Go Back

Go Back

Company or ticker...

Company or ticker...

BioTech

Collegium

Collegium Pharmaceutical develops pain medicines like Xtampza ER and Nucynta ER for patients with chronic, severe pain.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

COLL

1.5B

2.0

29.6

64.39%

Key Facts

Ticker

M. Cap

PS

PE

COLL

1.5B

2.0

29.6

YTD

10MA

20MA

50MA

200MA

64.39%

$COLL

Navigation

Start Here

Watchlist

Portfolio

Live Feed

Market Model

Dashboard

About

Connect

Reach out on X

Market is closed 💤

03:57 AM

Made with

Copyright 2025 © The Fullstack Investor

Disclaimer

Privacy Policy

Imprint

Terms & Conditions

Manage Membership

Disclaimer

The information on this website is for general informational purposes only and does not constitute financial advice. Any investment decisions made based on this content are at your own risk. The Fullstack Investor assumes no liability for the information presented, its accuracy, and completeness. You should conduct your own independent research. The author assumes no liability for any loss or damage arising from reliance on this information.

Navigation

Start Here

Watchlist

Portfolio

Live Feed

Market Model

Dashboard

About

Connect

Reach out on X

Market is closed 💤

03:57 AM

Made with

Copyright 2025 © The Fullstack Investor

Disclaimer

Privacy Policy

Imprint

Terms & Conditions

Manage Membership

Disclaimer

The information on this website is for general informational purposes only and does not constitute financial advice. Any investment decisions made based on this content are at your own risk. The Fullstack Investor assumes no liability for the information presented, its accuracy, and completeness. You should conduct your own independent research. The author assumes no liability for any loss or damage arising from reliance on this information.

Navigation

Start Here

Watchlist

Portfolio

Live Feed

Market Model

Dashboard

About

Connect

Reach out on X

Market is closed 💤

03:57 AM

Made with

Copyright 2025 © The Fullstack Investor

Disclaimer

Privacy Policy

Imprint

Terms & Conditions

Manage Membership

Disclaimer

This content is for informational purposes only and does not constitute financial advice. Please do your own research. No liability is accepted for any loss or damage arising from the use of this content.

Disclaimer

This content is for informational purposes only and does not constitute financial advice. Please do your own research. No liability is accepted for any loss or damage arising from the use of this content.

The Fullstack Investor

by Lin

v1.2

Join Now

Join Now

The Fullstack Investor

by Lin

v1.2

Join Now

Join Now

The Fullstack Investor

by Lin

v1.2

Join Now

Join Now

Join Now

Join Now